Filter
460
Text search:
Delta
Featured
Recommendations
51
New Publications
150
Language
Document type
No document type
197
Studies & Reports
91
Guidelines
86
Fact sheets
22
Situation Updates
19
Strategic & Response Plan
18
Manuals
13
Training Material
4
Infographics
3
Brochures
2
Resource Platforms
2
Videos
2
Online Courses
1
Countries / Regions
Myanmar / Burma
53
Nigeria
44
Venezuela
31
Brazil
20
Latin America and the Carribbean
12
Bangladesh
11
Global
10
India
8
Germany
8
Africa
7
Colombia
6
Congo, Democratic Republic of
5
South Sudan
5
Kenya
5
Argentina
5
South Africa
4
Chile
4
Western and Central Europe
4
Paraguay
4
Senegal
3
Uganda
3
Indonesia
3
Mozambique
3
Ecuador
3
Botswana
3
Sierra Leone
2
Liberia
2
Cameroon
2
Nepal
2
Iraq
2
Zambia
2
Malawi
2
Namibia
2
Peru
2
Ukraine
2
El Salvador
2
Bolivia
2
Angola
2
Lesotho
2
West and Central Africa
2
Vietnam
2
Mali
1
USA
1
Ethiopia
1
Zimbabwe
1
Haiti
1
Philippines
1
Somalia
1
Jordan
1
Afghanistan
1
Lebanon
1
Syria
1
Chad
1
Papua New Guinea
1
Eswatini/ Swaziland
1
Honduras
1
East and Southern Africa
1
South–East Asia Region
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Asia
1
Italy
1
Southern Africa
1
Iran
1
France
1
Authors & Publishers
Publication Years
Category
Countries
253
Key Resources
18
Clinical Guidelines
15
Public Health
11
Women & Child Health
11
Capacity Building
9
Pharmacy & Technologies
6
Annual Report MEDBOX
1
Toolboxes
COVID-19
145
Planetary Health
31
Mental Health
22
Natural Hazards
12
Refugee
11
Rapid Response
10
Global Health Education
10
NTDs
8
HIV
7
AMR
7
Cholera
6
TB
6
Caregiver
6
Conflict
5
Pharmacy
3
Disability
2
Ebola
2
Health Financing Toolbox
2
NCDs
2
Polio
1
Typhoon
1
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph
...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita
...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in
...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported
...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr
...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth
...
The overall objective of the framework is to support WHO and Members States in meaningful engagement of people living with NCDs, and mental health and neurological conditions to co-create and enhance related policies, programmes and services. This framework will contribute to advancing understanding
...
L’objectif général de ce cadre est de permettre à l’OMS et à ses États Membres d’assurer la participation significative des personnes vivant avec des maladies non transmissibles, des problèmes de santé mentale et neurologiques, via un processus de cocréation et de renforcement des poli
...
Le 13ème programme général de travail (PGT) 2019-2023 de l’OMS va amorcer bientôt sa dernière année de mise en oeuvre. Cependant, le chemin vers l’objectif du « triple milliard » semble encore long, à savoir « faire en sorte qu’un milliard de personnes supplémentaires bénéficient
...
This publication is part of WHO 75th anniversary and aims to capture key successes in public health globally and in Namibia. It includes contributory messages from the Head of State, Prime Minister and the Minister of Health and Social Services.
The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (i
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline
...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
This guide presents a basis for understanding how diarrhoeal diseases are currently influenced by climate and weather, and may be further exacerbated by climate change. It is a technical guide on how to conduct a Vulnerability & Adaptation assessment for diarrhoeal diseases and climate change, and p
...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa
...
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a
...
Background
Asthma remains highly prevalent, with more severe symptoms in low-income to middle-income countries (LMICs) compared with high-income countries. Identifying risk factors for severe asthma symptoms can assist with improving outcomes. We aimed to determine the prevalence, severity and ris
...
As Uganda builds back from the COVID-19 shock, the Ugandan government is strengthening its commitment to a more gender-inclusive and sustainable economy. This report supports these efforts by describing the gendered impacts of COVID-19 and provides recommendations for Ugandan policy makers and World
...
